TB continues to pose a challenge to Liberia’s healthcare system. In 2023, 17,000 people were estimated to have developed the disease, and 4,700 lives were lost to it. With nearly 1,800 people also living with both TB and HIV, and drug-resistant TB cases persisting, the demand for early, accessible diagnosis remains high.
Our involvement in Liberia has grown steadily over the years. In 2016, we partnered with the National Social Security and Welfare Corporation (NASSCORP) to build and equip a Diagnostic Centre. The facility was outfitted with MRI, CT, ultrasound, mammography, X-ray equipment, and integrated RIS/PACS systems to support comprehensive imaging services.
A year later, in 2017, we delivered an ultra-portable digital X-ray system to the Ministry of Health to help improve diagnostic reach. More recently, in 2023, a Delft Light system was provided through the Global Drug Facility (GDF) to support the National Tuberculosis Programme’s efforts in expanding mobile screening capacity.
